Evommune (EVMN) Other Non-Current Assets (2024 - 2026)

Evommune (EVMN) has 3 years of Other Non-Current Assets data on file, last reported at $1.4 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.4 million, up 577.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 577.4% YoY), and the FY2025 annual result was $1.4 million, up 607.5% from the prior year.
• Other Non-Current Assets was little changed at $1.4 million in Q1 2026 per EVMN's latest filing, from $1.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $1.4 million in Q4 2025 and troughed at $200000.0 in Q4 2024.
• A 3-year average of $808666.7 and a median of $808500.0 in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets jumped 607.5% in 2025, then soared 577.4% in 2026.
• A 3-year view of Other Non-Current Assets shows it stood at $200000.0 in 2024, then jumped by 607.5% to $1.4 million in 2025, then slipped by 0.42% to $1.4 million in 2026.
• Business Quant data shows EVMN's Other Non-Current Assets at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.